BioCentury
ARTICLE | Clinical News

Veregen sinecatechins regulatory update

March 25, 2013 7:00 AM UTC

Medigene said the Czech Republic approved Veregen sinecatechins to treat genital warts. The company said marketing partner Nordic Pharma, part of Nordic Group (Paris, France), plans to launch the drug this year in the Czech Republic, as well as in Slovakia, Poland and Hungary, where it is also approved. The topical formulation of polyphenols extracted from green tea leaves is marketed in the U.S., Germany, Austria, Spain and Switzerland. ...